ArriVent BioPharma reported total assets of $417.09M and total liabilities of $23.61M for the quarter ended Sep 2026, up 27.7% year over year. This balance sheet covers 16 quarters of results from Dec 2022 through Sep 2026, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 | Sep2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Current Assets | ||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 163.37M | 150.39M | 317.40M | 298.70M | 282.90M | 74.29M | 49.87M | 112.77M | 112.67M | 45.54M | 62.10M | 154.68M | 113.58M | |||
| Short-term InvestmentsInvestments (Current) | 144.57M | 126.21M | 122.92M | 187.59M | 267.28M | 264.28M | 218.44M | 279.64M | ||||||||
| Cash & Current Investments | 163.37M | 150.39M | 317.40M | 298.70M | 282.90M | 218.86M | 176.08M | 235.69M | 300.27M | 312.82M | 326.38M | 373.12M | 393.22M | |||
| Current Deferred Tax AssetsCurrent Deferred Tax | -19.98M | -44.12M | ||||||||||||||
| Prepaid Assets | 19.25M | 9.58M | 10.09M | 9.84M | 9.54M | 8.12M | 9.71M | 14.46M | 20.95M | 20.08M | 22.32M | 21.05M | 23.39M | |||
| Current Assets | 182.62M | 159.97M | 327.48M | 308.51M | 292.40M | 226.98M | 185.79M | 250.15M | 321.22M | 332.90M | 348.70M | 394.17M | 416.62M | |||
| Non-Current Assets | ||||||||||||||||
| Long-Term Investments | 47.68M | 29.41M | 18.79M | 5.11M | ||||||||||||
| Intangibles | 8.11M | 10.68M | ||||||||||||||
| Goodwill & Intangibles | 8.11M | 10.68M | ||||||||||||||
| Long-Term Deferred Tax | 0.03M | 0.07M | ||||||||||||||
| Other Non-Current Assets | 0.07M | 2.84M | 0.11M | 0.13M | 0.13M | 0.13M | 0.18M | 0.48M | 0.18M | 0.26M | 0.23M | 0.18M | 0.17M | |||
| Non-Current Assets | 0.21M | 3.13M | 0.36M | 0.34M | 0.31M | 47.96M | 29.71M | 19.36M | 5.34M | 0.27M | 0.60M | 0.55M | 0.47M | |||
| Assets | 182.83M | 163.10M | 327.84M | 308.86M | 292.71M | 274.94M | 215.50M | 269.51M | 326.56M | 333.17M | 349.30M | 394.72M | 417.09M | |||
| Liabilities | ||||||||||||||||
| Current Liabilities | ||||||||||||||||
| Accounts Payables | 3.09M | 4.53M | 4.10M | 3.81M | 4.65M | 3.78M | 4.36M | 4.06M | 5.93M | 5.93M | 8.73M | 2.22M | 2.62M | |||
| Payables | 3.09M | 4.53M | 4.10M | 3.81M | 4.65M | 3.78M | 4.36M | 4.06M | 5.93M | 5.93M | 8.73M | 2.22M | 2.62M | |||
| Accumulated Expenses | 5.14M | 6.95M | 5.73M | 8.13M | 10.36M | 13.33M | 8.45M | 15.48M | 15.57M | 20.00M | 16.17M | 25.31M | 20.74M | |||
| Other Accumulated Expenses | 5.94M | 0.06M | 0.04M | 0.12M | 0.14M | 0.07M | 0.16M | 0.16M | 0.11M | 0.02M | 0.04M | 0.00M | ||||
| Current Taxes | 154.63M | |||||||||||||||
| Total Current Liabilities | 8.36M | 11.62M | 9.98M | 12.10M | 15.16M | 17.27M | 12.95M | 19.64M | 21.56M | 25.95M | 25.00M | 27.84M | ||||
| Non-Current Liabilities | ||||||||||||||||
| Preferred Stock Liabilities | 259.57M | 304.51M | 304.49M | 304.49M | 304.49M | |||||||||||
| Non-Current Deferred Tax LiabilityNon-Current Deferred Tax | -0.03M | -0.07M | ||||||||||||||
| Operating Leases | 0.13M | 0.18M | 0.14M | 0.10M | 0.06M | 0.01M | 0.14M | 0.10M | 0.06M | 0.01M | 0.32M | 0.03M | 0.26M | |||
| Total Liabilities | 267.94M | 316.29M | 10.12M | 12.20M | 15.22M | 17.29M | 12.95M | 19.64M | 21.56M | 25.95M | 25.32M | 27.88M | 23.61M | |||
| Shareholder's Equity | ||||||||||||||||
| Common Equity | -85.11M | -97.09M | -118.46M | -132.60M | -153.19M | 317.72M | 296.66M | 277.49M | 257.65M | 202.54M | 249.87M | 305.00M | 307.22M | 323.98M | 366.84M | 393.48M |
| Liabilities and Shareholders Equity | 182.83M | 163.10M | 327.84M | 308.86M | 292.71M | 274.94M | 215.50M | 269.51M | 326.56M | 333.17M | 349.30M | 394.72M | 417.09M | |||
| Retained Earnings | -88.51M | -157.85M | -175.30M | -197.14M | -217.70M | -238.33M | -302.72M | -334.12M | -369.10M | -404.64M | -448.00M | -497.90M | -538.20M |
Pull ArriVent BioPharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=AVBP&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "AVBP", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=AVBP&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();